Cynthia X. Qian

ORCID: 0000-0003-2109-7254
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal Development and Disorders
  • Glaucoma and retinal disorders
  • Retinal and Optic Conditions
  • Retinal Imaging and Analysis
  • Retinal and Macular Surgery
  • Corneal surgery and disorders
  • Retinopathy of Prematurity Studies
  • Intraocular Surgery and Lenses
  • Corneal Surgery and Treatments
  • Ocular Oncology and Treatments
  • Ocular Diseases and Behçet’s Syndrome
  • Photoreceptor and optogenetics research
  • Ophthalmology and Eye Disorders
  • Neonatal and fetal brain pathology
  • Traumatic Ocular and Foreign Body Injuries
  • Ocular Surface and Contact Lens
  • Trace Elements in Health
  • Nuclear Structure and Function
  • Ocular Infections and Treatments
  • Vascular Malformations Diagnosis and Treatment
  • Ophthalmology and Visual Impairment Studies
  • RNA Research and Splicing
  • Cytokine Signaling Pathways and Interactions
  • Drug-Induced Ocular Toxicity

Université de Montréal
2014-2025

Hôpital Maisonneuve-Rosemont
2010-2025

McGill University
2007-2024

Centre Hospitalier Universitaire Sainte-Justine
2022-2023

Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal
2020-2022

Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal
2020-2022

Massachusetts Eye and Ear Infirmary
2014-2017

W.K. Kellogg Foundation
2017

University of Michigan
2016-2017

Michigan United
2017

An important, unmet clinical need is for cost-effective, reliable, easy-to-use, and portable retinal photography to evaluate preventable causes of vision loss in children. This study presents the feasibility a novel smartphone-based imaging device tailored pediatric fundus.Several modifications children were made our previous device, including child-friendly 3D printed housing animals, attention-grabbing targets, enhanced image stitching, video-recording capabilities. Retinal photographs...

10.1167/tvst.8.3.29 article EN cc-by-nc-nd Translational Vision Science & Technology 2019-05-30

Signaling through MEK-->ERK1/2 and PI3 kinases is implicated in many aspects of cell physiology, including the survival oxidant exposure. Oxidants play a role numerous physiological pathophysiological processes, which rely on transport out nucleus. However, how oxidative stress impacts nuclear trafficking not well defined.

10.1371/journal.pone.0008420 article EN cc-by PLoS ONE 2009-12-23

To determine the influence of omega-3 supplementation on vitreous vascular endothelial growth factor A (VEGF-A) levels in patients with exudative age-related macular degeneration (wet AMD) receiving intravitreal anti-VEGF treatment.Prospective, randomized, open-label, single-center, clinical trial, consecutive interventional case series.The study included 3 cohorts wet AMD and a control group epiretinal membrane or hole. Twenty being treated were randomized to daily antioxidants, zinc,...

10.1016/j.ajo.2014.07.036 article EN cc-by-nc-sa American Journal of Ophthalmology 2014-08-01

Platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) make profound contributions to both physiology pathology. While it is widely believed that direct (PDGF-mediated) activation the primary mode of activating PDGFRs, discovery they can also be activated indirectly begs question relevance indirect PDGFRs. In context a blinding eye disease, PDGFRα results in persistent signaling, which suppresses level p53 thereby promotes viability cells drive pathogenesis. Under same...

10.1128/mcb.01248-14 article EN Molecular and Cellular Biology 2015-03-03

Cortisol has been suggested as a risk factor for choroidal thickening, which may lead to retinal changes.To compare thickness measurements using optical coherence tomography (OCT) in patients with endogenous active Cushing's syndrome (CS) and evaluate the occurrence of abnormalities same group patients.Cross-sectional study.Outpatient clinic.Eleven female CS hypercortisolism state determined by presence at least two abnormal from urinary cortisol 24 h, no suppression low dose dexamethasone...

10.3389/fendo.2016.00154 article EN cc-by Frontiers in Endocrinology 2016-12-08

Purpose: To report the effect of superficial keratectomy combined with subconjunctival bevacizumab injection in 2 cases corneal neovascularization (NV). Methods: An interventional case series was undertaken on patients NV: 1 due to sclerokeratitis secondary rheumatoid arthritis and other Terrien marginal degeneration. Both underwent (2.5 mg/0.1 mL). Results: Corneal NV regressed surgical removal showed no signs recurrence after 3 months follow-up. reported dramatic subjective improvement...

10.1097/ico.0b013e31817c41e3 article EN Cornea 2008-09-19

Purpose: Previous studies have shown that vitreous stimulates degradation of the tumor suppressor protein p53 and knockdown phosphatidylinositol 5-phosphate 4-kinases (PI5P4Kα -β) abrogates proliferation p53-deficient cells. The purpose this study was to determine whether stimulated expression PI5P4Kα -β suppression would inhibit vitreous-induced cellular responses experimental proliferative vitreoretinopathy (PVR). Methods: encoded by PIP4K2A 2B, respectively, in human ARPE-19 cells were...

10.1167/iovs.16-19405 article EN cc-by-nc-nd Investigative Ophthalmology & Visual Science 2016-07-29

Purpose: To investigate whether vascular endothelial growth factor (VEGF)–suppression durations contribute to our understanding of clinical trial outcomes by simulating vitreous molar concentrations (Cvm) intravitreal aflibercept (IVT-AFL) and brolucizumab (IVT-BRO) using pharmacokinetic (PK) modeling. Methods: A PK model simulated Cvm after single-dose IVT-AFL, IVT-BRO, ranibizumab (IVT-RAN), extrapolated intraocular VEGF-suppression thresholds durations. Vitreous multidose regimens used in...

10.1167/tvst.10.4.9 article EN cc-by-nc-nd Translational Vision Science & Technology 2021-04-13
Coming Soon ...